Company Filing History:
Years Active: 2024-2025
Title: The Innovations of Edward Deramon
Introduction
Edward Deramon is an accomplished inventor based in New Haven, CT. He has made significant contributions to the field of molecular biology, particularly in the development of compounds aimed at treating heart failure. With a total of two patents to his name, Deramon's work is paving the way for innovative therapeutic solutions.
Latest Patents
Deramon's latest patents focus on molecular degraders of extracellular proteins. The disclosures describe compounds of Formula Ia, which include an asialoglycoprotein receptor (ASGPR) binding moiety and an anti-βAR binding moiety. These compounds are designed to prevent, treat, and ameliorate heart failure when administered in therapeutically effective amounts. The potential impact of these innovations could be transformative for patients suffering from this condition.
Career Highlights
Edward Deramon is affiliated with Yale University, where he continues to engage in groundbreaking research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Some of his notable coworkers include David Caianiello and David Spiegel. Their collaborative efforts contribute to the dynamic research environment at Yale University.
Conclusion
Edward Deramon's contributions to the field of molecular biology and his innovative patents highlight his role as a leading inventor in the medical research community. His work promises to make a significant difference in the treatment of heart failure.